The latest consensus on coronary heart disease treatment was released with the participation of more than 40 leading cardiovascular experts. "Chinese Expert Consensus on the Clinical Application of Tongxinluo in the Prevention and Treatment of Coronary Heart Disease" (hereinafter referred to as the "Consensus") - was formulated in strict accordance with international consensus standards (ESC Guidelines Evidence Classification and Recommendation Standards).

release. There are 11.39 million patients with coronary heart Disease in my country. The total hospitalization cost is 116.959 billion yuan.